Lialda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

PRObiotic VSL#3 ® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis
Condition:   Ulcerative Colitis Interventions:   Dietary Supplement: VSL#3®;   Drug: Mesalamine;   Drug: Placebo Sponsors:   VSL Pharmaceuticals;   Actial Farmaceutica S.r.l. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2018 Category: Research Source Type: clinical trials